Literature DB >> 180019

Cyclic 3':5'-nucleotide phosphodiesterase. Ca2+ confers more helical conformation to the protein activator.

Y P Liu, W Y Cheung.   

Abstract

The ultraviolet spectrum of a protein activator of cyclic nucleotide phosphodiesterase and adenylate cyclase purified to homogeneity from bovine brain displayed absorption peaks at 252, 259, 265, 269, and 277 nm. The activator contained no phosphate and did not serve as a substrate for cyclic adenosine 3':5'-monophosphate- or cyclic guanosine 3':5'-monophosphate-dependent protein kinases. The activator binds Ca2+, and the active form appears to be a Ca2+ activator complex (Lin, Y.M., Liu, Y.P., and Cheung, W.Y. (1974) J. Biol. Chem. 249, 4943-4954). Optical rotatory dispersion measurement showed that the Ca2+-free activator exhibited a reduced mean residue rotation ([m']231) of -5700, corresponding to 39% of helical content. In the presence of Ca2+, the [m']231 was increased to -7500, corresponding to 57% of helical content. The Ca2+ -induced conformational change was corroborated by a chemical method. In the presence of Ca2+, the activator was more resistant to trypsin inactivation, presumably because proteins with more helical structures are more resistant to tryptic attack. The activator is rich in aspartate and glutamate. Chemical block of some of the carboxyl groups with glycine ethyl ester or methoxyamine diminished the [m']231 of the activator and its activity, suggesting that blockade of some of the carboxyl groups in the activator unfolded the molecule, leading to a loss of activity. We conclude that Ca2+, which confers more helical structure to the activator, converts the inactive, less helical structure to the active, more helical structure, and that chemical modification of the activator leading to unfolding of the molecule abolishes its biological activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180019

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Effects of manganese on cyclic GMP levels in the rat ductus deferens.

Authors:  K D Schultz; K Schultz; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-07       Impact factor: 3.000

2.  Peptide antisera as sequence-specific probes of protein conformational transitions: calmodulin exhibits calcium-dependent changes in antigenicity.

Authors:  J Gariépy; T A Mietzner; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Azidocalmodulin derivatives. Activation of, and binding to, three target proteins: aorta myosin light-chain kinase, erythrocyte (Mg2+ + Ca2+)-dependent ATPase and cardiac sarcoplasmic-reticulum kinase.

Authors:  A Molla; M T Hincke; S Katz; R Lazaro
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

4.  Physical and enzymatic properties of myosin from porcine brain.

Authors:  D S Hobbs; D W Frederiksen
Journal:  Biophys J       Date:  1980-11       Impact factor: 4.033

Review 5.  Calmodulin.

Authors:  Y M Lin
Journal:  Mol Cell Biochem       Date:  1982-06-11       Impact factor: 3.396

6.  The divalent cation dependence of liver glycogen synthase phosphatase activity.

Authors:  D P Gilboe; F Q Nuttall
Journal:  Mol Cell Biochem       Date:  1980-05-28       Impact factor: 3.396

7.  Calmodulin accelerates the rate of polymerization of human platelet actin and alters the structural characteristics of actin filaments.

Authors:  G A Piazza; R W Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.